Association of lung immune prognostic index (LIPI) with survival of first line immune checkpoint inhibitors single agent or in combination with chemotherapy in untreated advanced NSCLC patients

被引：0
|
作者：
Blanc-Durand, F. [1 ]
Auclin, E. [2 ]
Planchard, D. [1 ]
Ponce Aix, S. [3 ]
Hendriks, L. [4 ]
Sullivan, I. G. [5 ]
Saravia, D. [6 ]
Routy, B. [7 ]
Lopez Castro, R. [8 ]
Pilotto, S. [9 ]
Aboubakar, F. [10 ]
Kassouf, E. [11 ]
Rodriguez, A. [12 ]
Amores Martin, A. [13 ]
Bluthgen, M. V. [14 ]
Duchemann, B. [15 ]
Caramella, C. [16 ]
Nadal, E. [17 ]
Besse, B. [1 ]
Mezquita, L. [1 ]
机构：
[1] Inst Gustave Roussy, Med Oncol, Villejuif, France
[2] Hop European George Pompidou, Gastrointestinal & Med Oncol Dept, Paris, France
[3] Univ Hosp 12 Octubre, Med Oncol, Madrid, Spain
[4] Maastricht Univ, Med Ctr, Pulm Dis, Maastricht, Netherlands
[5] Hosp Santa Creu & Sant Pau, Dept Med Oncol, Barcelona, Spain
[6] Jackson Mem Hosp, Hematol Oncol Dept, Miami, FL 33136 USA
[7] Univ Montreal, Res Ctr, Hematooncol, Montreal, PQ, Canada
[8] Univ Clin Hosp Valladolid, Med Oncol, Valladolid, Spain
[9] AOU Integrata Borgo Roma Verona, Med Oncol, Verona, Italy
[10] UC Louvain Brussels Woluwe, Dept Oncol Thorac, Brussels, Belgium
[11] Ctr Hosp Reg Lanaudiere, Med Oncol, St Charles Borromee, PQ, Canada
[12] Inst Clin Malalties Hematol & Oncol, Med Oncol, Barcelona, Spain
[13] Hosp Clin Univ Salamanca, Med Oncol, Salamanca, Spain
[14] Hosp Aleman, Med Oncol, Buenos Aires, DF, Argentina
[15] Hop Avicenne, Med Oncol, Bobigny, France
[16] Inst Gustave Roussy, Radiol, Villejuif, France
[17] ICO, Med Oncol, Barcelona, Spain
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
17P
引用
收藏
页码：5 / 5
页数：1
相关论文
共 50 条
  • [1] Association of the LIPI With Survival and Response in Advanced NSCLC Patients Treated With Immune Checkpoint Inhibitors
    Zhi, X.
    Zhang, Z.
    Li, W.
    Yan, X.
    Zhang, F.
    Han, X.
    Yuan, F.
    Ma, J.
    Wang, L.
    Tao, H.
    Li, X.
    Zhang, S.
    Ge, X.
    Hu, Y.
    Wang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S582 - S582
  • [2] Association of the Lung Immune Prognostic Index (LIPI) with Outcomes for Immune Checkpoint Inhibitors in Diffuse SCLC Patients
    Mezquita, L.
    Aix, S. Ponce
    Auclin, E.
    Navarro, A.
    Planchard, D.
    Sullivan, I.
    Zalcman, G.
    Mazieres, J.
    Hendriks, L.
    Caramella, C.
    Majem, M.
    Lavaud, P.
    Nana, F. Aboubakar
    Felip, E.
    Paz-Ares, L.
    Besse, B.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S973 - S974
  • [3] Correlation of the Lung Immune Prognostic Index (LIPI) and PDL1 Status with Outcomes for Immune Checkpoint Inhibitors in Advanced NSCLC Patients
    Mezquita, L.
    Park, W.
    Arbour, K.
    Auclin, E.
    Hendriks, L.
    Planchard, D.
    Saravia, D.
    Ponce Aix, S.
    Nadal, E.
    Audigier-Valette, C.
    Carnio, S.
    Adam, J.
    Ruffinelli, J. C.
    Zalcman, G.
    Numico, G.
    Sullivan, I.
    Paz-Ares, L.
    Dingemans, A.
    Novello, S.
    Hellmann, M.
    Lopes, G.
    Besse, B.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S488 - S488
  • [4] The Lung Immune Prognostic Index (LIPI), a predictive score for immune checkpoint inhibitors in advanced non-small cell lung cancer (NSCLC) patients
    Mezquita, L.
    Auclin, E.
    Charrier, M.
    Ferrara, R.
    Masip, J. Remon
    Planchard, D.
    Aix, S. Ponce
    Paz-Ares, L.
    Lahmar, J.
    Leroy, L.
    Audigier-Valette, C.
    Cuairan, J. Zeron-Medina
    Lopez, P. Garrido
    Brosseau, S.
    Mazieres, J.
    Caramella, C.
    Adam, J.
    Chaput, N.
    Soria, J-C.
    Besse, B.
    ANNALS OF ONCOLOGY, 2017, 28
  • [5] Association of the pretreatment lung immune prognostic index with survival outcomes in advanced gastric cancer patients treated with immune checkpoint inhibitors
    Hou, Baicun
    Wang, Peng
    Liu, Tingting
    Chen, Shixue
    Li, Tao
    Zhang, Sujie
    Tao, Haitao
    Li, Xiaoyan
    Hu, Yi
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2021, 45 (05)
  • [6] Lung Immune Prognostic Index (LIPI) in Advanced NSCLC Patients Treated with Immunotherapy, Chemotherapy and both Combined Upfront.
    Blanc-Durand, F.
    Mielgo Rubio, X.
    Auclin, E.
    Ponce-Aix, S.
    Lopez Castro, R.
    Nadal, E.
    Planchard, D.
    Routy, B.
    Hendriks, L.
    Sullivan, I.
    Dempsey, N.
    Pilotto, S.
    Aboubakar, F.
    Pinato, D. J.
    Castonguay, M.
    Rodriguez, A.
    Amores, A.
    Bluthgen, M. V.
    Duchemann, B.
    Cruz Castellano, P.
    Aguado De La Rosa, C.
    Sereno Moyano, M.
    Ruffinelli, J.
    Lopez, G.
    Caramella, C.
    Besse, B.
    Mezquita, L.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S205 - S206
  • [7] Dynamic monitoring of lung immune prognostic index (LIPI) in thoracic tumours treated with immune checkpoint inhibitors
    Lopez Escola, Cristina
    Flores, Alvaro
    Robles, Marta
    Donnelly, Harry
    Hercules, Darlene
    Gomez, Kyle
    Roman, Juan
    Del Rio Valencia, Juan Carlos
    Moreno, Mamta
    Ballesteros, David
    LUNG CANCER, 2023, 178 : S46 - S46
  • [8] Prognostic Nutritional Index and Lung Immune Prognostic Index as Prognostic Predictors for Combination Therapies of Immune Checkpoint Inhibitors and Cytotoxic Anticancer Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer
    Tanaka, Satomi
    Uchino, Junji
    Yokoi, Takashi
    Kijima, Takashi
    Goto, Yasuhiro
    Suga, Yoshifumi
    Katayama, Yuki
    Nakamura, Ryota
    Morimoto, Kenji
    Nakao, Akira
    Hibino, Makoto
    Tani, Nozomi
    Takeda, Takayuki
    Yamaguchi, Hiroyuki
    Tachibana, Yusuke
    Takumi, Chieko
    Hiraoka, Noriya
    Takeshita, Masafumi
    Onoi, Keisuke
    Chihara, Yusuke
    Taniguchi, Ryusuke
    Yamada, Takahiro
    Matsui, Yohei
    Hiranuma, Osamu
    Morimoto, Yoshie
    Iwasaku, Masahiro
    Tokuda, Shinsaku
    Kaneko, Yoshiko
    Yamada, Tadaaki
    Takayama, Koichi
    DIAGNOSTICS, 2022, 12 (02)
  • [9] Response Assessment and Subgroups Analysis According to the Lung Immune Prognostic Index (LIPI) for Immunotherapy in Advanced NSCLC Patients
    Mezquita, L.
    Auclin, E.
    Ferrara, R.
    Caramella, C.
    Charrier, M.
    Remon, J.
    Planchard, D.
    Ponce, S.
    Paz-Ares, L.
    Lahmar, J.
    Leroy, L.
    Audigier-Valette, C.
    Zeron-Medina, J.
    Garrido, P.
    Zalcman, G.
    Mazieres, J.
    Adam, J.
    Chaput, N.
    Soria, J.
    Besse, B.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2151 - S2152
  • [10] The Lung Immune Prognostic Index (LIPI) stratifies prognostic groups in advanced non-small cell lung cancer (NSCLC) patients
    Aldea, Mihaela
    Benitez, Jose Carlos
    Mezquita, Laura
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (04) : 967 - 970
12345